ANNIVERSARY REVIEW: Octreotide, 40 years later
| Autor: | Leo J. Hofland, Steven W. J. Lamberts |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pediatrics
medicine.medical_specialty business.industry Endocrinology Diabetes and Metabolism Octreotide 030209 endocrinology & metabolism General Medicine History 20th Century medicine.disease 03 medical and health sciences 0302 clinical medicine Endocrinology 030220 oncology & carcinogenesis Internal medicine Acromegaly Endocrine Gland Neoplasms Medicine Humans business medicine.drug |
| Zdroj: | European journal of endocrinology. 181(5) |
| ISSN: | 1479-683X |
| Popis: | Octreotide remains 40 years after its development a drug, which is commonly used in the treatment of acromegaly and GEP-NETs. Very little innovation that competes with this drug occurred over this period. This review discusses several aspects of 40 years of clinical use of octreotide, including the application of radiolabeled forms of the peptide. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|